Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Watson

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
Cancer Medicine|August 16, 2022
Single-agent gemcitabine in patients with advanced, pre-treated angiosarcoma: A multicenter, retrospective studySarah Watson, Benjamin Verret, Stanislas Ropert, et al.
Cancer Medicine|December 20, 2022
Patterns of care and outcome of CIC-rearranged sarcoma patients: A nationwide study of the French sarcoma groupMehdi Brahmi, Nathalie Gaspar, Justine Gantzer, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 30, 2023
Impact of guideline adherence and expert center referral on the early management and outcomes of uterine sarcoma patients: A retrospective analysis from the French NETSARC networkClarisse Richaud, Floriane Jochum, Gabrielle Journo, et al.
Nature Communications|September 12, 2024
A metabolic crosstalk between liposarcoma and muscle sustains tumor growthGabrielle Manteaux, Alix Amsel, Blanche Riquier-Morcant, et al.
NPJ Precision Oncology|July 18, 2024
Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohortNicolas Jacquin, Ronan Flippot, Julien Masliah-Planchon, et al.
Acta Neuropathologica Communications|October 31, 2021
CNS tumors with YWHAE:NUTM2 and KDM2B-fusions present molecular similarities to extra-CNS tumors having BCOR internal tandem duplication or alternative fusionsArnault Tauziède-Espariat, Gaëlle Pierron, Delphine Guillemot, et al.
Nature Communications|September 12, 2024
Cellular origin and clonal evolution of human dedifferentiated liposarcomaNadège Gruel, Chloé Quignot, Laëtitia Lesage, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2026
Natural history and treatment sensitivity of alveolar soft part sarcoma: A national multicenter analysis from the French sarcoma groupEva Kalfala, Alexandra Meurgey, Clémence Hénon, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 9, 2026
How should primary pulmonary sarcoma be staged? Results of an International Multicenter AnalysisTheresa Stork, Dagmar Adamkova, Clemens Aigner, et al.
JTCVS Open|December 31, 2025
Outcome of patients with curative-intent treatment for primary pulmonary sarcoma: Results from an international multicenter retrospective studyStephane Collaud, Theresa Stork, Dagmar Adamkova, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Cancer Medicine|August 16, 2022
Single-agent gemcitabine in patients with advanced, pre-treated angiosarcoma: A multicenter, retrospective studySarah Watson, Benjamin Verret, Stanislas Ropert, et al.
Cancer Medicine|December 20, 2022
Patterns of care and outcome of CIC-rearranged sarcoma patients: A nationwide study of the French sarcoma groupMehdi Brahmi, Nathalie Gaspar, Justine Gantzer, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 30, 2023
Impact of guideline adherence and expert center referral on the early management and outcomes of uterine sarcoma patients: A retrospective analysis from the French NETSARC networkClarisse Richaud, Floriane Jochum, Gabrielle Journo, et al.
Nature Communications|September 12, 2024
A metabolic crosstalk between liposarcoma and muscle sustains tumor growthGabrielle Manteaux, Alix Amsel, Blanche Riquier-Morcant, et al.
NPJ Precision Oncology|July 18, 2024
Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohortNicolas Jacquin, Ronan Flippot, Julien Masliah-Planchon, et al.
Acta Neuropathologica Communications|October 31, 2021
CNS tumors with YWHAE:NUTM2 and KDM2B-fusions present molecular similarities to extra-CNS tumors having BCOR internal tandem duplication or alternative fusionsArnault Tauziède-Espariat, Gaëlle Pierron, Delphine Guillemot, et al.
Nature Communications|September 12, 2024
Cellular origin and clonal evolution of human dedifferentiated liposarcomaNadège Gruel, Chloé Quignot, Laëtitia Lesage, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2026
Natural history and treatment sensitivity of alveolar soft part sarcoma: A national multicenter analysis from the French sarcoma groupEva Kalfala, Alexandra Meurgey, Clémence Hénon, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 9, 2026
How should primary pulmonary sarcoma be staged? Results of an International Multicenter AnalysisTheresa Stork, Dagmar Adamkova, Clemens Aigner, et al.
JTCVS Open|December 31, 2025
Outcome of patients with curative-intent treatment for primary pulmonary sarcoma: Results from an international multicenter retrospective studyStephane Collaud, Theresa Stork, Dagmar Adamkova, et al.
Pageof 11